Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model

American Journal of Obstetrics and Gynecology

Volumn 185, Issue 1, 2001, Pages 178-181

  Forestier, François ^a,b,c,d   De Renty, Patrick ^a,b,c,d   Peytavin, Gilles ^a,b,c,d   Dohin, Elisabeth ^a,b,c,d   Farinotti, Robert ^a,b,c,d   Mandelbrot, Laurent ^a,b,c,d  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICHAT HOSPITAL   (France)

^c Hôpital Cochin ^*  (France)

^d Produits Roche   (United Kingdom)

Author keywords

Human immunodeficiency virus and pregnancy; Maternal fetal transfer; Perfused placenta; Saquinavir

Indexed keywords

HUMAN SERUM ALBUMIN; PROTEINASE INHIBITOR; SAQUINAVIR;

ARTICLE; DRUG CLEARANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IN VITRO STUDY; MODEL; PLACENTA PERFUSION; PLACENTAL TRANSFER; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL;

EID: 0034922735     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.113319     Document Type: Article

References (25)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
2. Antiretroviral therapy for pregnant women
3. Public Health Service Task Force recommendations for the use of antiretrovirol drugs in pregnant wowen infected with HIV-1 for maternal health and reducing perinatal HIV-1 transmission in the United States
4. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
5. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine
6. Transfer across the perfused human placenta of antipyrine, sodium and leucine
7. Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model
8. Criteria for evaluating perfusion experiments and presentation of results
9. Azidothymidine (zidovudine) transport by the human placenta
10. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta
11. Nucleoside transport by perfused human placenta
12. Transfer of dideoxyinosine across the human isolated placenta
13. Further observations on zidovudine transfer and metabolism by human placenta
14. The maternal-fetal transfer of lamivudine in the ex vivo human placenta
15. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)
16. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring
17. Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort
18. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients
19. Saquinavir: A review of its pharmacology and clinical potential in the management of HIV infection
20. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women
21. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
22. Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model
23. PACTG 353: A phase I study of safety, pharmacokinetics, and antiviral activity of combination nelfinavir, ZDV, and 3TC in HIV-infected pregnant women and their infants
24. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine